North America’s medical devices industry saw a drop of 27.27% in cross border deal activity in Q3 2022
Led by SD Biosensor and SJL Partners’s $1.54bn private equity deal with Meridian Bioscience, North America’s medical devices industry saw…
Led by SD Biosensor and SJL Partners’s $1.54bn private equity deal with Meridian Bioscience, North America’s medical devices industry saw…
Total medical devices industry cross border venture financing deals worth $1.7bn were announced globally in Q3 2022, led by $223m venture financing of Cleerly, according to GlobalData’s deals database. Embed…
Led by $3.12bn private equity deal with Evident, Asia-Pacific’s medical devices industry saw a drop of 32.82% in cross border deal activity during Q3 2022, when compared to the last…
Bain Capital’s $3.12bn private equity deal with Evident was the medical devices industry’s biggest cross border deal of Q3 2022 as cross border deals worth $8.1bn were announced globally in…
Led by $225m venture financing of Delfi Diagnostics, total medical devices industry venture financing deals worth $2.7bn were announced in North America in Q3 2022, according to GlobalData’s deals database.…
Total medical devices industry venture financing deals worth $4bn were announced globally in Q3 2022, led by $225m venture financing of Delfi Diagnostics, according to GlobalData’s deals database. Embed this…
Total medical devices private equity deals worth $6.7bn were announced globally in Q3 2022, with Bain Capital’s $3.12bn deal with Evident's being biggest investment, according to GlobalData’s deals database. Embed…